Related Experiment Video
Updated: Jul 30, 2026
Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
Published on: May 4, 2015
Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we?
G V Nair1, P A Gurbel, S Y Fuzaylov
1Sinai Center for Thrombosis Research, Baltimore, MD 21215, USA.
Insights
Diagnosing acute myocardial infarction (heart attack) requires better tools. Combining cardiac markers with platelet activation indicators may improve risk assessment for chest pain patients in the emergency department.
Area of Science:
- Emergency Medicine
- Cardiology
- Biochemistry
Background:
- Chest pain is a common emergency department complaint, with over 10% of patients diagnosed with acute myocardial infarction (AMI).
- Current diagnostic tools like electrocardiograms and cardiac markers have limitations in specificity and sensitivity for early detection of myocardial necrosis.
- Accurate risk stratification is crucial to avoid unnecessary hospital admissions and inappropriate patient discharges.
Purpose of the Study:
- To review current biochemical diagnostic tools for acute myocardial infarction.
- To explore the potential benefits of combining myocardial necrosis markers with indicators of platelet activation.
- To evaluate if a combined approach enhances risk stratification for unstable coronary syndromes.
Main Methods:
- Literature review of available biochemical diagnostic tools.
- Discussion of myocardial necrosis markers.
- Analysis of indicators of platelet activation.
- Hypothetical evaluation of combined marker strategies.
Main Results:
- Current diagnostic methods for myocardial infarction have limitations.
- Combining markers of myocardial necrosis with platelet activation indicators is proposed.
- This combined approach may offer improved accuracy in risk stratification.
Conclusions:
- There is a need for improved diagnostic methods in emergency medicine for acute myocardial infarction.
- Combining cardiac biomarkers and platelet activation markers shows promise for better risk stratification.
- Further research into combined diagnostic strategies is warranted for managing chest pain patients.
Abstract:
Each year, at least 5 million patients in the United States present to hospital emergency departments with the complaint of chest pain, and more than 10% of them will be diagnosed with acute myocardial infarction. One of the foremost tasks of the emergency department physician is to avoid unnecessary admissions and concomitantly to minimize the number of patients discharged home inappropriately. Currently available diagnostic tools, including the electrocardiogram and myocardial markers, have several shortcomings, including low specificity, and delayed sensitivity for the timely detection of myocardial necrosis. Therefore, the search for better methods of rapidly identifying patients with unstable coronary syndromes is one of the utmost priorities of modern emergency medicine. Available biochemical diagnostic tools are discussed in this review, focusing on the potential benefits of combining myocardial necrosis markers with indicators of platelet activation. It is hypothesized that such a combined approach may be more powerful in myocardial infarction risk stratification than separate marker determination.
More Related Videos
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
11:17A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:30Acute Coronary Syndrome I: Introduction
01:30Acute Coronary Syndrome III: Diagnostic Studies